Navigation Links
Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014
Date:9/1/2010

NEW YORK, Sept. 1 /PRNewswire/ -- TriMark Publications, LLC (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014. Regenerative medicine is a technique to treat injuries and diseases with specially-grown tissues by way of several different methods, including stem cell therapy and tissue engineering.

Before scientific advances such as stem cells, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not) or a surgeon's skilled hands. Now, the area of regenerative medicine promises to revolutionize humanity's ability to remedy countless physical maladies that have afflicted humans and other animals through techniques like stem cells and tissue engineering.

In this study, TriMark Publications reviews the market for regenerative medicine solutions. The areas covered in this study include: available and emerging technologies in the field, the U.S. and global market size for regenerative medicine products, and profiles of companies that are focusing on the regenerative medicine sector.

Reasons to Buy TriMark Content

  • Data is updated regularly in accordance with changes in the industries our reports cover.
  • Information is specifically designed to help individuals who work in the industries the content covers remain competitive in the marketplace.
  • Content contains detailed sales data, market share information and emerging trends, all of which impact the sectors companies focused on biotechnology, life sciences, healthcare, pharmaceuticals and medical devices operate in.
  • Your competitors are buying TriMark content!

About TriMark Publications, LLC

TriMark Publications is a global leader in the biotechnology, healthcare and life sciences publishing. For more information, please visit http://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.


'/>"/>
SOURCE TriMark Publications, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
2. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
3. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
4. Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
5. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
6. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
7. Novocell Receives a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
8. Stem Cell Assurance Unveils Physician Network Offering Regenerative Cell Cosmetic and Reconstructive Applications
9. Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine
10. iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming
11. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):